A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.
Clinical trial NCT04322266 · COMPLETED
Trial details
- NCT number
- NCT04322266
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-21
- Primary completion
- 2019-02-13
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.